Healthcare Research Reports

Provides the topic, method, and file download of Assessment of clinical safety and efficacy for weight loss supplements (garcinia cambogia extractt, irvingia gabonesis seed extract) in humans
SUBJECT PUBLISH

Assessment of clinical safety and efficacy for weight loss supplements (garcinia cambogia extractt, irvingia gabonesis seed extract) in humans

PUBLISH DATE 2017.06.30
FILE [Executive Summary] Assessment of clinical safety and efficacy for weight loss supplements (garcinia cambogia extractt, irvingia gabonesis seed extract) in humans.pdf

Summary

We aimed to develop a framework for policy-making guidelines of weight loss supplements, by developing an informational booklet on the use of some more popular supplements. To this end, we analyzed the clinical safety and efficacy, as well as reports of adverse reactions to these products, and we received consultation from clinical specialists. The specific objectives of this study are as follows. 


First, to analyze the clinical safety and efficacy of Garcinia cambogia extract and Irvingia gabonensis seed extract.
Second, to analyze the adverse effects or reports of adverse reactions involving Garcinia cambogia extract and Irvingia gabonensis seed extract.
Third, to develop an informational booklet about Garcinia cambogia extract and Irvingia gabonensis seed extract.

Reference Data

Journal Publication

Copyright

Provide copyright protection.

Creative Commons License

· CC BY-NC-ND

Korea Open Government License

· BY
· NC
· SA

Contact Us

Report & Quote. - Report : +82-2-2174-2883 - Quote : +82-2-2174-2787
Prev The Impact of National Liver Cancer Surveillance Program on the Early detection, Mortality and Medical cost
Next Economic evaluation of intravitreal injectionof anti-vascular endothelial growth factor in ocular diseases